ATE205392T1 - Verfahren zur senkung des intraokulären druckes im auge von säugetieren durch verabreichung von gamma-aminobuttersäure-agonisten - Google Patents
Verfahren zur senkung des intraokulären druckes im auge von säugetieren durch verabreichung von gamma-aminobuttersäure-agonistenInfo
- Publication number
- ATE205392T1 ATE205392T1 AT93907540T AT93907540T ATE205392T1 AT E205392 T1 ATE205392 T1 AT E205392T1 AT 93907540 T AT93907540 T AT 93907540T AT 93907540 T AT93907540 T AT 93907540T AT E205392 T1 ATE205392 T1 AT E205392T1
- Authority
- AT
- Austria
- Prior art keywords
- chloro
- aminobutyric acid
- pharmaceutically acceptable
- acceptable salt
- gamma
- Prior art date
Links
- 239000003477 4 aminobutyric acid receptor stimulating agent Substances 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title 1
- 230000004410 intraocular pressure Effects 0.000 title 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 abstract 4
- ZJQHPWUVQPJPQT-UHFFFAOYSA-N muscimol Chemical compound NCC1=CC(=O)NO1 ZJQHPWUVQPJPQT-UHFFFAOYSA-N 0.000 abstract 4
- 150000003839 salts Chemical class 0.000 abstract 4
- ANTSCNMPPGJYLG-UHFFFAOYSA-N chlordiazepoxide Chemical compound O=N=1CC(NC)=NC2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 ANTSCNMPPGJYLG-UHFFFAOYSA-N 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 abstract 2
- ZXRVKCBLGJOCEE-UHFFFAOYSA-N Gaboxadol Chemical compound C1NCCC2=C1ONC2=O ZXRVKCBLGJOCEE-UHFFFAOYSA-N 0.000 abstract 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 abstract 2
- SAADBVWGJQAEFS-UHFFFAOYSA-N flurazepam Chemical compound N=1CC(=O)N(CCN(CC)CC)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1F SAADBVWGJQAEFS-UHFFFAOYSA-N 0.000 abstract 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 abstract 2
- UGBJGGRINDTHIH-UHFFFAOYSA-N piperidine-4-sulfonic acid Chemical compound OS(=O)(=O)C1CCNCC1 UGBJGGRINDTHIH-UHFFFAOYSA-N 0.000 abstract 2
- ZDZDSZQYRBZPNN-UHFFFAOYSA-N 4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-6-ium-3-olate;hydrochloride Chemical compound Cl.C1NCCC2=C1ONC2=O ZDZDSZQYRBZPNN-UHFFFAOYSA-N 0.000 abstract 1
- 208000010412 Glaucoma Diseases 0.000 abstract 1
- 206010030043 Ocular hypertension Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229960004782 chlordiazepoxide Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960003529 diazepam Drugs 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229960003528 flurazepam Drugs 0.000 abstract 1
- MGIYRDNGCNKGJU-UHFFFAOYSA-N isothiazolinone Chemical compound O=C1C=CSN1 MGIYRDNGCNKGJU-UHFFFAOYSA-N 0.000 abstract 1
- QVBUOPGWPXUAHT-UHFFFAOYSA-N thiomuscimol Chemical compound NCC1=CC(O)=NS1 QVBUOPGWPXUAHT-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/856,012 US6077839A (en) | 1992-03-19 | 1992-03-19 | Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists |
| PCT/US1993/002402 WO1993018762A2 (en) | 1992-03-19 | 1993-03-16 | Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE205392T1 true ATE205392T1 (de) | 2001-09-15 |
Family
ID=25322685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93907540T ATE205392T1 (de) | 1992-03-19 | 1993-03-16 | Verfahren zur senkung des intraokulären druckes im auge von säugetieren durch verabreichung von gamma-aminobuttersäure-agonisten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6077839A (de) |
| EP (1) | EP0630240B1 (de) |
| JP (1) | JPH07505156A (de) |
| AT (1) | ATE205392T1 (de) |
| AU (1) | AU3810893A (de) |
| CA (1) | CA2132102A1 (de) |
| DE (1) | DE69330749T2 (de) |
| ES (1) | ES2162815T3 (de) |
| WO (1) | WO1993018762A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU736514B2 (en) * | 1995-07-13 | 2001-07-26 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Non-allosteric gabaa agonists for treating sleep disorders |
| DE19525598C2 (de) * | 1995-07-13 | 1997-09-25 | Max Planck Gesellschaft | Schlafmittel |
| WO2001022941A1 (en) * | 1999-09-28 | 2001-04-05 | H. Lundbeck A/S | Melt granulated composition and modified release dosage form prepared from said composition |
| CN1501795A (zh) * | 2001-02-13 | 2004-06-02 | ��������²�ʿ��ѧҩ������ɷ����� | 用于治疗眼部神经变性疾病的gaba-受体-调节剂 |
| US20040242457A1 (en) * | 2003-05-27 | 2004-12-02 | Ashby Charles R. | Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent |
| EP2309858A4 (de) | 2008-07-31 | 2011-09-14 | Dekel Pharmaceuticals Ltd | Zusammensetzungen und verfahren zur behandlung von entzündungserkrankungen |
| WO2011113904A1 (en) * | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
| US8784835B2 (en) * | 2012-07-02 | 2014-07-22 | Trent Austin | Method for producing muscimol and/or reducing ibotenic acid from amanita tissue |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3467756A (en) * | 1967-03-16 | 1969-09-16 | Merck & Co Inc | Composition and method for treating glaucoma |
| US3644643A (en) * | 1969-10-13 | 1972-02-22 | Unimed Inc | Method of reducing intraocular pressure using glycine |
| US4363818A (en) * | 1975-06-04 | 1982-12-14 | Gottlieb Sheldon K | Method for relief of burning, itching, and pain of cutaneous and mucosal surfaces |
| US4171377A (en) * | 1978-08-11 | 1979-10-16 | Burton, Parsons & Co., Inc. | Ophthalmic solution of tranexamic acid |
| US4197301A (en) * | 1978-10-16 | 1980-04-08 | Allergan Pharmaceuticals, Inc. | Topical ophthalmic use of Prazosin |
| US4322440A (en) * | 1980-06-25 | 1982-03-30 | New York University | Anticonvulsive compositions and method of treating convulsive disorders |
| US4565821A (en) * | 1983-03-21 | 1986-01-21 | The Texas A&M University System | Method and ophthalmic composition for treating ocular hypertension and glaucoma with butyrophenones |
| US4837021A (en) * | 1986-12-31 | 1989-06-06 | Laboratoires P.O.S. | Two part tissue irrigating solution |
| US5066664A (en) * | 1990-02-28 | 1991-11-19 | Allergan, Inc. | 2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agents |
| US5091528A (en) * | 1990-09-12 | 1992-02-25 | Allergan, Inc. | 6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents |
-
1992
- 1992-03-19 US US07/856,012 patent/US6077839A/en not_active Expired - Fee Related
-
1993
- 1993-03-16 ES ES93907540T patent/ES2162815T3/es not_active Expired - Lifetime
- 1993-03-16 DE DE69330749T patent/DE69330749T2/de not_active Expired - Fee Related
- 1993-03-16 AU AU38108/93A patent/AU3810893A/en not_active Abandoned
- 1993-03-16 EP EP93907540A patent/EP0630240B1/de not_active Expired - Lifetime
- 1993-03-16 JP JP5516680A patent/JPH07505156A/ja active Pending
- 1993-03-16 CA CA002132102A patent/CA2132102A1/en not_active Abandoned
- 1993-03-16 AT AT93907540T patent/ATE205392T1/de not_active IP Right Cessation
- 1993-03-16 WO PCT/US1993/002402 patent/WO1993018762A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CA2132102A1 (en) | 1993-09-30 |
| EP0630240B1 (de) | 2001-09-12 |
| US6077839A (en) | 2000-06-20 |
| ES2162815T3 (es) | 2002-01-16 |
| JPH07505156A (ja) | 1995-06-08 |
| WO1993018762A3 (en) | 1993-10-28 |
| DE69330749D1 (de) | 2001-10-18 |
| EP0630240A1 (de) | 1994-12-28 |
| DE69330749T2 (de) | 2002-07-04 |
| WO1993018762A2 (en) | 1993-09-30 |
| AU3810893A (en) | 1993-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE195117T1 (de) | 1-amdinophenyl-pyrrolidone/piperidinone als blutblättchen-aggregations inhibitoren | |
| NO964939D0 (no) | Fremgangsmåte for fremstilling av virkestoffpreparater i form av en fast lösning av virkestoffet i en polymermatriks, samt virkestoffpreparater fremstilt ved hjelp av denne fremgangsmåte | |
| DE69633196D1 (de) | Heterocyclische verbindungen als h+-atpasen | |
| HUP0001062A2 (hu) | NAALADáz gátló hatású foszfinsavszármazékokat tartalmazó gyógyászati készítmények | |
| DE69330749D1 (de) | Verfahren zur senkung des intraokulären druckes im auge von säugetieren durch verabreichung von gamma-aminobuttersäure-agonisten | |
| WO2002009702A8 (en) | Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure | |
| DE69329381D1 (de) | Anti-ischaemisches arzneimittel | |
| AU6999796A (en) | Heterocyclic compounds as bradykinin antagonists | |
| CA2680324A1 (en) | Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds | |
| ATE192041T1 (de) | Arzneimittel zur prophylaxe und behandlung von katarakt | |
| DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
| WO1995034302A3 (en) | Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators | |
| US5190962A (en) | Treating hypertension | |
| MX9805317A (es) | Agente para la profilaxis y el tratamiento de complicaciones diabeticas. | |
| D'ANDREA et al. | Dual mechanism for cAMP-dependent modulation of Ca2+ signalling in articular chondrocytes | |
| JP2001505217A (ja) | チエニルシクロヘキシルアミン誘導体の新規な治療用途 | |
| ATE200277T1 (de) | Substituierte phenylamidine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
| Deckert et al. | Phenylarsine oxide and phorbol myristate acetate inhibit the CD3-induced rise of cytosolic Ca2+ in Jurkat cells by refilling internal Ca2+ stores | |
| EP1364953A4 (de) | Triazolochinazolin- und pyrazolotriazolopyrimidinderivate, medizinische zusammensetzungen, mittel mit adenosin-a3-rezeptoraffinität, mittel, die den augeninnendruck senken, zubereitungen zur prävention und behandlung von glaukom und verfahren zur senkung des augeninnendrucks" | |
| IL117083A (en) | Pyridine and pyridazine derivatives processes for the production thereof and pharmaceutical compositions containing these compounds | |
| RU2003331C1 (ru) | Средство дл регулировани сокращени глазного зрачка | |
| KR900009696A (ko) | 신규 화합물 | |
| DK381983D0 (da) | Fremgangsmade til fremstilling af spiro (2h-1,4-benzodioxepin-3(5h)4'-piperidin-og-3'-pyrrolidinforbindelser | |
| AU710525B2 (en) | Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (GABA) agonists | |
| TH19375A (th) | การใช้แบบใหม่ของเบนโซ ( ) ควิโนลีน |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |